Skip to main content
Clinical Trials/IRCT201011275181N3
IRCT201011275181N3
Completed
Phase 3

A comparative study of the use of oxytocin (Iranian-made and foreign) in the induction of labor.

Caspian Pharmaceutical Company0 sites100 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
ong labor.
Sponsor
Caspian Pharmaceutical Company
Enrollment
100
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Caspian Pharmaceutical Company

Eligibility Criteria

Inclusion Criteria

  • one Fetal pregnancy; Cephalic presentation; intact amniotic membrane; Reactive NST; less than 3 uterus contraction per 10 minutes. Exclusion criteria: regular contraction (more than 6 contraction per hours); fetal death; Amniotomy contra indication; mother age less than 18 years; previous C/S; Multiparty (\>3\); Chorioamniotit; Asthma history; Multiple gestation; Placenta previa; Non Cephalic presentation; Glucoma; Vaginal bleeding; sensitivity to Prostoglandin; irregular in fetal heart rate; contra indication of vaginal delivery.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials